BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6690191)

  • 1. Responses of the systemic circulation and of the renin-angiotensin-aldosterone system to ketanserin at rest and exercise in normal man.
    Fagard R; Cattaert A; Lijnen P; Staessen J; Vanhees L; Moerman E; Amery A
    Clin Sci (Lond); 1984 Jan; 66(1):17-25. PubMed ID: 6690191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin II on arterial pressure, renin and aldosterone during exercise.
    Fagard R; Lijnen P; Amery A
    Eur J Appl Physiol Occup Physiol; 1985; 54(3):254-61. PubMed ID: 3905392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man.
    Zoccali C; Zabludowski JR; Isles CG; Murray GD; Inglis GC; Robertson JI; Fraser R; Ball SG
    Br J Clin Pharmacol; 1983 Sep; 16(3):305-11. PubMed ID: 6626423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension.
    Zabludowski JR; Zoccali C; Isles CG; Murray GD; Robertson JI; Inglis GC; Fraser R; Ball SG
    Br J Clin Pharmacol; 1984 Mar; 17(3):309-16. PubMed ID: 6712863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension.
    Fagard R; Fiocchi R; Lijnen P; Staessen J; Moerman E; de Schaepdryver A; Amery A
    Br Heart J; 1984 Feb; 51(2):149-56. PubMed ID: 6362688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ketanserin on cardiovascular, sympatho-adrenal and endocrine systems during physical exercise in man.
    Defer G; Guezennec CY; Fraitag B; Lhoste F
    Fundam Clin Pharmacol; 1987; 1(2):135-43. PubMed ID: 3315914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic response to converting enzyme inhibition at rest and exercise in humans.
    Fagard R; Lijnen P; Vanhees L; Amery A
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Sep; 53(3):576-81. PubMed ID: 6290435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects on central haemodynamics and body fluid volumes of ketanserin in essential hypertension studies at rest and during dynamic exercise.
    Omvik P; Lund-Johansen P
    J Hypertens; 1983 Dec; 1(4):405-12. PubMed ID: 6681181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of opioid antagonism on the haemodynamic and hormonal responses to exercise.
    Staessen J; Fiocchi R; Bouillon R; Fagard R; Hespel P; Lijnen P; Moerman E; Amery A
    Clin Sci (Lond); 1988 Sep; 75(3):293-300. PubMed ID: 2843314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of calcium antagonism on the resting and exercise-stimulated renin-aldosterone axis.
    Hespel P; Lijnen P; Fiocchi R; Lissens W; Moerman E; Amery A
    Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):461-7. PubMed ID: 3316874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic response to chronic ketanserin treatment in essential hypertension.
    Fagard R; Fiocchi R; Lijnen P; Staessen J; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S128-9. PubMed ID: 2412034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous ketanserin on plasma catecholamines and renin activity in normal volunteers.
    Reimann IW; Ratge D; Wisser H; Klotz U
    Eur J Clin Pharmacol; 1985; 28(3):273-7. PubMed ID: 3159583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostaglandin synthesis inhibition on blood pressure and humoral factors in exercising, sodium-deplete normal man.
    Staessen J; Fagard R; Lijnen P; Moerman E; De Schaepdryver A; Amery A
    J Hypertens; 1983 Aug; 1(2):123-30. PubMed ID: 6397516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of felodipine on blood pressure and humoral factors in sodium-replete humans at rest and during exercise.
    Lijnen P; Hespel P; Fagard R; Staessen J; M'Buyamba-Kabangu JR; Moerman E; Amery A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S122-5. PubMed ID: 2455111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and neurohumoral effects of ketanserin, a 5-HT2 receptor antagonist in patients with congestive heart failure.
    Majid PA; Morris WM; Sole MJ
    Can J Cardiol; 1987 Mar; 3(2):70-4. PubMed ID: 3567710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ketanserin on hemodynamics, plasma-catecholamine concentrations, and serotonin uptake by platelets in volunteers and patients with congestive heart failure.
    Grobecker H; Gessler I; Delius W; Dominiak P; Kees F
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S102-4. PubMed ID: 2412024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of the systemic pulmonary circulation to labetalol at rest and during exercise.
    Fagard R; Lijnen P; Amery A
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):13S-17S. PubMed ID: 7046773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
    Kinugawa T; Endo A; Kato M; Kato T; Ahmmed GU; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y; Yoshida A; Shigemasa C
    Cardiology; 1997; 88(3):238-45. PubMed ID: 9129844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin antagonism at rest and during exercise in sodium-deplete man.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L; Bogaert M; Moerman E; De Schaepdryver A
    J Appl Physiol Respir Environ Exerc Physiol; 1978 Sep; 45(3):403-7. PubMed ID: 701125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
    MacFadyen RJ; Tree M; Lever AF; Reid JL
    Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.